Recovery of chronic Parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen

Neuron

Volumn 22, Issue 4, 1999, Pages 743-750

  Luquin, M Rosario ^a   Montoro, Rafael J ^c   Guillén, Javier ^a   Saldise, Laura ^a   Insausti, Ricardo ^b   Del Río, Joaquín ^a   López Barneo, José ^c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Universidad de Castilla La Mancha   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; BRADYKINESIA; CAROTID BODY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MONKEY; MOTOR PERFORMANCE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; TREMOR;

EID: 0342308802     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80733-3     Document Type: Article

References (45)

1. Baloh, R.H., Tansey, M.G., Lampe, P.A., Fahrner, T.J., Enomoto, H., Simburger, K.S., Leitner, M.L., Araki, T., Johnson, E.M., Jr., and Milbrandt, J. (1998). Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-RET receptor complex. Neuron 21, 1291-1302.
2. Björklund, A., and Stenevi, U. (1985). Intracerebral neural grafting. In Neural Grafting in the Mammalian CNS, A. Björklund and U. Stenevi, eds. (Amsterdam: Elsevier), pp. 3-14.
3. Björklund, A., Lindvall, O., Isacson, O., Brundin, P., Wictorin, K., Strecker, R.E., Clarke, D.J., and Dunnett, S.B. (1987). Mechanisms of action of intracerebral neural implants: Studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci. 10, 509-516.
4. Bohn, M.C., Cupit, L.C., Marciano, F., and Gash, D.M. (1987). Adrenal medullary grafts enhance recovery of striatal dopaminergic fibers. Science 237, 913-916.
5. Boyce, S., Rupniak, M.J., Stevenson, M.J., and Iversen, S.D. (1990). Nigrostriatal damage is required for induction of dyskinesias by I-dopa in squirrel monkey. Clin. Neuropharmacol. 13, 448-458.
6. Brownell, A.-L., Jenkins, B.G., Elmaleh, D.R., Deacon, T.W., Spealman, R.D., and Isacson, O. (1998). Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease. Nat. Med. 4, 1308-1312.
7. Czyzyk-Krzeska, M.F., Bayliss, D.A., Lawson, E.E., and Millhorn, D.E. (1992). Regulation of tyrosine hydroxylase gene expression in the rat carotid body by hypoxia. J. Neurochem. 58, 1538-1546.
8. Deacon, T., Schumacher, J., Dinsmore, J., Thomas, C., Palmer, P., Kott, S., Edge, A., Penney, D., Kassissieh, S., Dempsey, P., and Isacson, O. (1997). Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3, 350-353.
9. Espejo, E.F., Montoro, R.J., Armengol, J.A., and López-Barneo, J. (1998). Cellular and functional recovery of parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 20, 197-206.
10. Fidone, S.J., and González, C. (1986). Initiation and control of chemoreceptor activity in the carotid body. In Handbook Of Physiology: The Respiratory System II, A. Fishman, ed. (Washington, DC: American Physiological Society), pp. 247-312.
11. Fishman, M.C., Greene, W.L., and Platika, D. (1985). Oxygen chemoreception by carotid body cells in culture. Proc. Natl. Acad. Sci. USA 82, 1448-1450.
12. Freed, W.J., Morihisa, J.M., Spoor, E., Hoffer, B.J., Olson, L., Seiger, A., and Wyatt, J. (1981). Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 292, 351-352.
13. Freed, C.R., Breeze, R.E., Rosenberg, N.L., Schneck, S.A., Kriek, E., Qi, J.X., Lone, T., Zhang, Y.B., Snyder, J.A., Wells, T.H., et al. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12 and 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327, 1549-1555.
14. Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, J., Russell, D., Martin, D., Lapchak, P.A., Collins, F., et al. (1996). Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-254.
15. Hagan, J.J., Middlemiss, D.N., Sharpe, P.C., and Poste, G.H. (1997). Parkinson's disease: Prospects for improved drug therapy. Trends Pharmacol. Sci. 18, 156-163.
16. Herrero, M.T., Pérez-Otaño, Y., Oset, C., Kastner, A., Hirsch, E.C., Agid, Y., Luquin, M.R., Obeso, J.A., and Del Río, J. (1993). GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience 56, 965-972.
17. Honda, Y. (1992). Respiratory and circulatory activities in carotid body resected humans. J. Appl. Physiol. 73, 1-8.
18. Horger, B.A., Nishimura, M.C., Armanini, M.P., Wang, L.C., Poulsen, K.T., Rosenblad, C., Kirik, D., Moffat, B., Simmons, L., Johnson, E., Jr., et al. (1998). Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18, 4929-4937.
19. Kotzbauer, P.T., Lampe, P.A., Heuckeroth, R.O., Golden, J.P., Créedon, D.J., Johnson, E.M., Jr., and Milbrandt, J. (1996). Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384, 467-470.
20. Kordower, J.H., Freeman, T.B., Snow, B.J., Vingerhoets, F.J.G., Mufson, E.J., Sanberg, P.R., Hauser, R.A., Smith, D.A., Nauert, G.M., Perl, D.P., and Olanow, C.W. (1995). Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118-1124.
21. Lang, A.E., and Lozano, A.M. (1998a). Parkinson's disease. First part. New Engl. J. Med. 339, 1044-1053.
22. Lang, A.E., and Lozano, A.M. (1998b). Parkinson's disease. Second part. New Engl. J. Med. 339, 1130-1142.
23. Langston, J.W., Irwin, I., Langsten, E.B., and Forno, S. (1984). Pargyline prevents MPTP-induced parkinsonism in primates. Science 225, 1480-1482.
24. Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. (1993). GDNF: A glial cell line-derived neurotrophic factor for mid-brain dopaminergic neurons. Nature 260, 1130-1132.
25. López-Barneo, J. (1996). Oxygen-sensing by ion channels and the regulation of cellular functions. Trends Neurosci. 19, 435-440.
26. 2 in type I chemoreceptor cells. Science 241, 580-582.
27. Luquin, R., Laguna, J., and Obeso, J. (1992). Selective D2 receptor stimulation induces dyskinesias in parkinsonian monkeys. Ann. NeuRol. 31, 551-554.
28. Milbrandt, J., de Sauvage, F.J., Fahrner, T.J., Baloh, R.H., Leitner, M.L., Tansey, M.G., Lampe, P.A., Heuckeroth, R.O., Kotzbauer, P.T., Simburger, K.S., et al. (1998). Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20, 245-253.
29. Nakao, N., Itakura, T., Uematsu, Y., and Komai, N. (1995). Transplantation of cultured sympathetic ganglionic neurons into parkinsonian rat brain: Survival and function of graft. Acta Neurochir. (Wien) 133, 61-67.
30. Nosrat, C.A., Tomac, A., Lindqvist, E., Lindskog, S., Humpel, C., Strömberg, I., Ebendal, T., Hoffer, B., and Olson, L. (1996). Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res. 286, 191-207.
31. Pérez-Otaño, I., Herrero, M.T., Oset, C., De Ceballos, M.L., Luquin, M.R., Obeso, J.A., and Del Río, J. (1991). Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res. 567, 127-132.
32. Poulsen, K.T., Armanini, M.P., Klein, R.D., Hynes, M.A., Phillips, H.S., and Rosenthal, A. (1994). Tgfβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252.
33. Rosenblad, C., Martínez-Serrano, A., and Björklund, A. (1998). Intrastriatal glial-cell-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82, 129-137.
34. Rosenthal, A. (1998). Auto transplants for Parkinson's disease? NeuRon 20, 169-172.
35. Schmidt-Kastner, R., Tomac, A., Hoffer, B.J., Bektesh, S., Rosenzweig, B., and Olson, L. (1994). Glial cell line-derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Mol. Brain Res. 26, 325-330.
36. Schwarting, R.K.W., and Huston, J.P. (1996). The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50, 275-331.
37. Senut, M.-C., Suhr, ST., and Gage, F.H. (1996). Intracerebral xenografts: Sertoli cells to the rescue? Nat. Biotech. 14, 1650-1651.
38. Sladek, J.R., Jr., and Gash, D.M. (1988). Nerve cell grafting in Parkinson's disease. J. Neurosurg. 68, 337-351.
39. + channels and hypertrophy in chromaffin-like arterial chemoreceptors. Proc. Natl. Acad. Sci. USA 89, 9469-9473.
40. 2 chemoreceptors by chronic hypoxia and cyclic AMP in vivo. J. Neurosci. 15, 2192-2202.
41. Szabo, J., and Cowan, W.M. (1984). A stereotaxic atlas of the brain of the Cynomolgus monkey (Macaca fascicularis). J. Comp. Neurol. 222, 265-300.
42. Tomac, A., Lindqvist, E., Lin, L.-F.H., Ögren, S.O., Young, D., Hoffer, B.J., and Olson, J. (1995). Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
43. 2+ entry and quantal dopamine secretion in carotid body glomus cells. Proc. Natl. Acad. Sci. USA 91, 10208-10211.
44. Yurek, D.M., and Sladek, J.R. (1990). Dopamine cell replacement: Parkinson's disease. Annu. Rev. Neurosci. 13, 415-440.
45. Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A., and Stricker, E.M. (1990). Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends NeuRosci. 13, 290-296.